金黄色葡萄球菌临床分离株对司帕沙星和诺氟沙星的摄取情况。
Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.
作者信息
Yoshida S, Kojima T, Inoue M, Mitsuhashi S
机构信息
Episome Institute, Gunma, Japan.
出版信息
Antimicrob Agents Chemother. 1991 Feb;35(2):368-70. doi: 10.1128/AAC.35.2.368.
Abstract
The amount of sparfloxacin uptake was higher than that of norfloxacin uptake in Staphylococcus aureus. Moreover, energy-dependent reduction in quinolone uptake, probably due to active efflux of the quinolone, was observed. The reduction in quinolone uptake appeared to be associated with quinolone resistance in S. aureus.
摘要
在金黄色葡萄球菌中，司帕沙星的摄取量高于诺氟沙星的摄取量。此外，观察到喹诺酮摄取的能量依赖性降低，这可能是由于喹诺酮的主动外排所致。喹诺酮摄取的降低似乎与金黄色葡萄球菌对喹诺酮的耐药性有关。
相似文献
1
Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.金黄色葡萄球菌临床分离株对司帕沙星和诺氟沙星的摄取情况。
Antimicrob Agents Chemother. 1991 Feb;35(2):368-70. doi: 10.1128/AAC.35.2.368.
2
Uptake of 3H-norfloxacin in methicillin-resistant Staphylococcus aureus.
J Antimicrob Chemother. 1991 Oct;28(4):491-7. doi: 10.1093/jac/28.4.491.
3
Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus.喹诺酮类药物的亲水性并非金黄色葡萄球菌外排介导耐药突变体活性降低的唯一因素。
Antimicrob Agents Chemother. 1996 Aug;40(8):1835-42. doi: 10.1128/AAC.40.8.1835.
4
Antibacterial activity of a new tetracyclic quinolone, No. 5290, against norfloxacin- and ciprofloxacin-resistant strains of Staphylococcus aureus.新型四环喹诺酮类药物5290对耐诺氟沙星和环丙沙星金黄色葡萄球菌菌株的抗菌活性
Chem Pharm Bull (Tokyo). 1991 Oct;39(10):2644-6. doi: 10.1248/cpb.39.2644.
5
Lack of effect of carbonyl cyanide m-chlorophenylhydrazone on KB-5246 accumulation by Staphylococcus aureus.羰基氰化物间氯苯腙对金黄色葡萄球菌积累KB - 5246无影响。
Antimicrob Agents Chemother. 1992 Apr;36(4):883-5. doi: 10.1128/AAC.36.4.883.
6
[Study on uptake of fluoroquinolones by Staphylococcus aureus].
Hua Xi Yi Ke Da Xue Xue Bao. 2000 Mar;31(1):18-20.
7
[Accumulation and efflux of quinolones by clinical isolates of Stenotrophomonas maltophilia].嗜麦芽窄食单胞菌临床分离株对喹诺酮类药物的蓄积与外排
Rev Esp Quimioter. 2000 Jun;13(2):176-81.
8
Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.由norA介导的喹诺酮耐药性：生理学特征及其与flqB的关系，flqB是金黄色葡萄球菌染色体上的一个喹诺酮耐药位点。
Antimicrob Agents Chemother. 1994 Jun;38(6):1345-55. doi: 10.1128/AAC.38.6.1345.
9
Mechanisms of 4-quinolone resistance in quinolone-resistant and methicillin-resistant Staphylococcus aureus isolates from Japan and China.来自日本和中国的喹诺酮耐药及耐甲氧西林金黄色葡萄球菌分离株中4-喹诺酮耐药机制
J Med Microbiol. 1995 Mar;42(3):214-9. doi: 10.1099/00222615-42-3-214.
10
Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus.
Antimicrob Agents Chemother. 1991 Dec;35(12):2562-7. doi: 10.1128/AAC.35.12.2562.
引用本文的文献
1
Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.奥美拉唑类似物的合成及其作为金黄色葡萄球菌多药外排泵NorA潜在抑制剂的评估。
Antimicrob Agents Chemother. 2007 Mar;51(3):831-8. doi: 10.1128/AAC.01306-05. Epub 2006 Nov 13.
2
Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.诺氟沙星抑制剂对金黄色葡萄球菌基因相关菌株中左氧氟沙星、环丙沙星和诺氟沙星的体外抗菌活性及抗生素后效应的影响。
Antimicrob Agents Chemother. 1999 Feb;43(2):335-40. doi: 10.1128/AAC.43.2.335.
3
Mode of action of sulfanilyl fluoroquinolones.磺胺基氟喹诺酮类的作用模式。
Antimicrob Agents Chemother. 1998 Jun;42(6):1495-8. doi: 10.1128/AAC.42.6.1495.
4
Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.主动外排作为肺炎链球菌对环丙沙星耐药的一种机制。
Antimicrob Agents Chemother. 1997 Sep;41(9):1973-8. doi: 10.1128/AAC.41.9.1973.
5
Intracellular accumulation of norfloxacin in Mycobacterium smegmatis.诺氟沙星在耻垢分枝杆菌中的细胞内积累。
Antimicrob Agents Chemother. 1995 Nov;39(11):2466-71. doi: 10.1128/AAC.39.11.2466.
6
Mechanisms of resistance to fluoroquinolones: state-of-the-art 1992-1994.氟喹诺酮类药物的耐药机制：1992 - 1994年的最新进展
Drugs. 1995;49 Suppl 2:29-35. doi: 10.2165/00003495-199500492-00006.
7
Mechanisms of quinolone resistance.喹诺酮耐药机制。
Infection. 1994;22 Suppl 2:S73-9. doi: 10.1007/BF01793570.
8
Sequential acquisition of norfloxacin and ofloxacin resistance by methicillin-resistant and -susceptible Staphylococcus aureus.耐甲氧西林和甲氧西林敏感金黄色葡萄球菌对诺氟沙星和氧氟沙星耐药性的序贯获得
Antimicrob Agents Chemother. 1993 Nov;37(11):2278-84. doi: 10.1128/AAC.37.11.2278.
9
Mechanisms of resistance to quinolones.喹诺酮类药物的耐药机制。
Drugs. 1993;45 Suppl 3:15-23. doi: 10.2165/00003495-199300453-00005.
10
In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises.对五种喹诺酮类药物的体外研究：随着喹诺酮类耐药性上升，相对效力变化的证据。
Antimicrob Agents Chemother. 1991 Nov;35(11):2329-34. doi: 10.1128/AAC.35.11.2329.
本文引用的文献
1
Mutational resistance to 4-quinolone antibacterial agents.对4-喹诺酮类抗菌药物的突变耐药性。
Eur J Clin Microbiol. 1984 Aug;3(4):347-50. doi: 10.1007/BF01977492.
2
Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.大肠杆菌K-12耐诺氟沙星突变体的分离与鉴定
Antimicrob Agents Chemother. 1986 Aug;30(2):248-53. doi: 10.1128/AAC.30.2.248.
3
Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli.鼠伤寒沙门氏菌和大肠杆菌外膜突变体对喹诺酮类药物敏感性的差异。
Antimicrob Agents Chemother. 1986 Mar;29(3):535-8. doi: 10.1128/AAC.29.3.535.
4
Endogenous active efflux of norfloxacin in susceptible Escherichia coli.诺氟沙星在敏感大肠杆菌中的内源性主动外排
Antimicrob Agents Chemother. 1988 Aug;32(8):1187-91. doi: 10.1128/AAC.32.8.1187.
5
Mechanisms of action of and resistance to ciprofloxacin.环丙沙星的作用机制及耐药性
Am J Med. 1987 Apr 27;82(4A):12-20.
6
Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli.来自耐氟喹诺酮大肠杆菌菌株的DNA促旋酶的纯化及特性
Antimicrob Agents Chemother. 1986 Nov;30(5):777-80. doi: 10.1128/AAC.30.5.777.
7
Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.大肠杆菌中诺氟沙星耐药性的遗传与生化特征分析
Antimicrob Agents Chemother. 1986 Apr;29(4):639-44. doi: 10.1128/AAC.29.4.639.
8
Norfloxacin resistance in a clinical isolate of Escherichia coli.大肠杆菌临床分离株中的诺氟沙星耐药性
Antimicrob Agents Chemother. 1987 Oct;31(10):1640-1. doi: 10.1128/AAC.31.10.1640.
9
Accumulation of enoxacin by Escherichia coli and Bacillus subtilis.大肠杆菌和枯草芽孢杆菌对依诺沙星的积累。
Antimicrob Agents Chemother. 1987 Sep;31(9):1348-54. doi: 10.1128/AAC.31.9.1348.
10
Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.由四环素或氯霉素筛选出的多重耐药性（Mar）大肠杆菌对氟喹诺酮类药物的交叉耐药性：除了外膜孔蛋白F（OmpF）减少外，药物积累减少与膜变化有关。
Antimicrob Agents Chemother. 1989 Aug;33(8):1318-25. doi: 10.1128/AAC.33.8.1318.
Zotero 插件